EP Patent

EP0461546A3 — Antiherpes peptide derivatives having a 1,4-dioxo-c4 n-terminus

Assigned to Bio Mega Boehringer Ingelheim Research Inc · Expires 1993-03-24 · 33y expired

What this patent protects

Disclosed herein are peptide derivatives of the formula R<1>NH-CO-Q-C(O)-NR<2>-CH[CH2C(O)-Y]-C(O)-NH-CH[CR<3>(R<4>)-COOH]-C(W) -NH-CHR<5>-Z wherein R<1> is an optionally substituted alkyl or optionally substituted phenylalkyl, R<2> is hyd…

USPTO Abstract

Disclosed herein are peptide derivatives of the formula R<1>NH-CO-Q-C(O)-NR<2>-CH[CH2C(O)-Y]-C(O)-NH-CH[CR<3>(R<4>)-COOH]-C(W) -NH-CHR<5>-Z wherein R<1> is an optionally substituted alkyl or optionally substituted phenylalkyl, R<2> is hydrogen or alkyl, R<3> and R<4> each independently is hydrogen or alkyl, or R<3> and R<4> are joined to form a cycloalkyl, R<5> is alkyl, cycloalkyl or (cycloalkyl)alkyl, Q is a divalent radical, for example, -CH2CH2-, -CH=CH- or 1,2-cyclohexanediyl, which serves as a two carbon spacer, W is oxo or thioxo, Y is, for example, an alkoxy or a monosubstituted or disubstituted amino, and Z is a terminal unit, for example, hydrogen, COOH or CH2OH. The derivatives are useful for treating herpes infections.

Drugs covered by this patent

Patent Metadata

Patent number
EP0461546A3
Jurisdiction
EP
Classification
Expires
1993-03-24
Drug substance claim
No
Drug product claim
No
Assignee
Bio Mega Boehringer Ingelheim Research Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.